The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dilacort 5 mg gastro-resistant tablets

Crescent Pharma International LimitedPA22699/001/002

Main Information

Trade NameDilacort 5 mg gastro-resistant tablets
Active SubstancesPrednisolone
Dosage FormGastro-resistant tablet
Licence HolderCrescent Pharma International Limited
Licence NumberPA22699/001/002

Group Information

ATC CodeH02AB Glucocorticoids
H02AB06 prednisolone


License statusAuthorised
Licence Issued04/01/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back